Redox Biology (Jun 2023)

UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis

  • Yu Gan,
  • Jun Deng,
  • Qian Hao,
  • Yingdan Huang,
  • Tao Han,
  • Jin-Guo Xu,
  • Min Zhao,
  • Litong Yao,
  • Yingying Xu,
  • Jianping Xiong,
  • Hua Lu,
  • Chunmeng Wang,
  • Jiaxiang Chen,
  • Xiang Zhou

Journal volume & issue
Vol. 62
p. 102705

Abstract

Read online

The eukaryotic ribosome is essential for cancer cell survival. Perturbation of ribosome biogenesis induces nucleolar stress or ribosomal stress, which restrains cancer growth, as rapidly proliferating cancer cells need more active ribosome biogenesis. In this study, we found that UTP11 plays an important role in the biosynthesis of 18S ribosomal RNAs (rRNA) by binding to the pre-rRNA processing factor, MPP10. UTP11 is overexpressed in human cancers and associated with poor prognoses. Interestingly, depletion of UTP11 inhibits cancer cell growth in vitro and in vivo through p53-depedednt and -independent mechanisms, whereas UTP11 overexpression promotes cancer cell growth and progression. On the one hand, the ablation of UTP11 impedes 18S rRNA biosynthesis to trigger nucleolar stress, thereby preventing MDM2-mediated p53 ubiquitination and degradation through ribosomal proteins, RPL5 and RPL11. On the other hand, UTP11 deficiency represses the expression of SLC7A11 by promoting the decay of NRF2 mRNA, resulting in reduced levels of glutathione (GSH) and enhanced ferroptosis. Altogether, our study uncovers a critical role for UTP11 in maintaining cancer cell survival and growth, as depleting UTP11 leads to p53-dependent cancer cell growth arrest and p53-independent ferroptosis.

Keywords